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Abstract. 
 
Background: Subjective memory complaints (SMCs) may be the first sign of cognitive decline in 
aging.  
Objective: To examine whether SMCs reported by oneself and informant predict cognitive change 
over 2 years among at-risk elderly people, and to determine the relationship of different types of 
SMCs (prospective and retrospective memory complaints) and change in cognitive function.  
Methods: This investigation is part of the FINGER project, which is a multicenter randomized 
controlled trial aiming at preventing cognitive decline in cognitively healthy older adults with increased 
risk of dementia. A subsample of 303 control-group participants (aged 60-80 years) and their informants 
(n=261) rated the frequency of SMCs, using the Prospective and Retrospective Memory Questionnaire 
(PRMQ). Cognitive performance was measured at baseline and at 1- and 2-year follow-up visits using 
a neuropsychological test battery.  
Results: Participants who reported more SMCs improved less in global cognition, executive function 
and memory during the subsequent 2 years in the fully-adjusted analyses. Self-reported RM problems 
predicted less improvement in all cognitive domains, whereas PM problems did not. Informant-
reported memory problems were not linked to subsequent change in cognition.  
Conclusion: Our results indicate that self-reported SMCs, measured with PRMQ, predict future 
cognitive change in several cognitive domains. By contrast, reports by informants were not linked to 
changes in cognition. Among cognitively healthy at-risk elderly individuals, the persons themselves 
observe more easily problems relevant for their future cognitive trajectories than their informants. 
 
Keywords: Aging, Cognition, Dementia, Memory  
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INTRODUCTION 
 
Memory impairments are often the first manifested symptoms of Alzheimer’s disease (AD) [1]. 
Especially deficits in episodic memory, but also in other cognitive domains, including executive 
function and processing speed have been observed years before the clinical dementia diagnosis [1]. 
Assessing subjective memory complaints (SMCs), everyday memory concerns expressed by people, 
is one approach in attempting to detect early signs of degenerative dementing processes and enable 
early diagnosis. SMCs have been related to the development of cognitive decline and dementia [2-4] 
and to underlying neurophysiological changes even among persons with normal cognitive function 
[5,6]. However, associations have not been found in all studies [2-4,7] and SMCs have also been 
suggested to have limited utility for the very early identification of AD [8,9]. Further, SMCs may be 
inconsistently related to current cognitive functioning, but more strongly linked with future cognitive 
decline [10].  
 
SMCs are very common among elderly individuals [7] and have been linked to a range of non-
cognitive factors, including depression [11], and to various demographic, clinical [7], and personality 
[12] characteristics. In addition, while memory self-awareness decreases during the progression of 
AD, it may show marked variability among persons with mild cognitive impairment [13].  
 
Self- and informant-reported SMCs have been shown to diverge in prodromal stages of AD [14]. In 
clinical settings self-reports are often associated with actual cognitive test performance among 
healthy controls, but among patients with mild cognitive impairment informant reports are more often 
associated with cognition [15,16]. In a population-based study [2] both self-reported SMCs and 
informant reports predicted future dementia or AD, independent of objective memory performance 
across 10-12 years follow-up time. In a non-demented clinical sample, informant complaints 
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improved accuracy of the Mini Mental State Examination (MMSE) in predicting probable AD over 
2 years but patient complaints did not [17]. A recent review suggested a higher risk of progression of 
cognitive impairment among individuals whose subjective complaints were corroborated by an 
informant [7]. 
 
Studies on SMCs have usually not assessed prospective (PM) and retrospective (RM) memory 
complaints separately. In short, PM is the ability to remember to perform a planned action or intention 
in the future, and RM refers to remembering the past events. Self-reported PM and RM complaints 
may offer important additional information with added discriminative power in identifying 
individuals at risk of future cognitive decline [18,19]. In our previous work both self-reported PM 
and RM complaints were linked to slower processing speed in cross-sectional analysis among 
cognitively healthy older persons at increased risk of dementia [20]. It has been suggested that PM 
failures may have greater impact on the lives of carers and, therefore, more likely to be reported [21]. 
In one study informant PM reports made an independent contribution to the prediction of AD over 
and above RM reports [22].  
 
The objective of this study is to examine whether SMCs, including both PM and RM complaints, 
assessed both by participants and informants predict future cognitive change (over 2 years) among 
healthy at-risk elderly people.  
 
METHODS 
 
Study design 
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The current study is part of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment 
and Disability (FINGER), (ClinicalTrials.gov identifier NCT01041989). The protocol and the main 
results of FINGER have been described earlier [23,24]. In brief, FINGER is a multi-center 
randomized controlled trial aiming to lower the risk of cognitive impairment in elderly persons at 
increased risk of cognitive decline. Participants received either an intensive multidomain intervention 
or regular health advice. The primary outcome was cognitive performance measured with the 
modified Neuropsychological Test Battery (NTB) [23]. FINGER has been approved by the 
Coordinating Ethics Committee of the Helsinki and Uusimaa Hospital District and written informed 
consent to perform this study was received. 
 
Participants 
 
Control group participants were included in this study, so that the role of SMCs in predicting cognitive 
change in a “non-intervention setting” can be assessed. Participants were 60–77 years of age at the 
beginning of the study. They were recruited from previous population-based, non-intervention 
surveys [25,26] that are well representative of the Finnish population [27]. Participants were 
prescreened using the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Dementia Risk 
Score, and those scoring at least 6 points (range 0–15 points, based on age, sex, education, systolic 
blood pressure, body mass index, total cholesterol, and physical activity, indicating presence of some 
dementia risk factors) were invited to the screening visit. This group of persons scoring at least 6 
points represents 84 % of the population in this age group [27]. They were further screened with the 
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological test 
battery. The Prospective and Retrospective Memory Questionnaire (PRMQ) was added to the study 
protocol after study onset, and thus, PRMQ data are available for the control-group participants who 
were included in the study after August 2010 (n=303). 
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For inclusion, at least one of the following criteria had to be met: (1) Word List Memory Task learning 
score (10 words x 3) ≤19 words; (2) Word List Recall ≤75%; or (3) Mini-Mental State Examination 
(MMSE) [28] ≤26/30 points. These criteria selected persons with cognitive performance at the mean 
level or slightly lower than expected for age according to Finnish population norms [29], but without 
substantial cognitive impairment. Nearly half of the screened participants fulfilled the inclusion 
criteria and were included in the study. The majority of the screened participants that were not 
included had CERAD test performance above the cut-off levels [27]. Exclusion criteria were 
conditions affecting safe engagement in the intervention (especially the exercise component): 
malignant diseases; major depression; dementia/substantial cognitive decline; MMSE< 20; 
symptomatic cardiovascular disease; revascularization within 1 year; severe loss of vision, hearing, 
or communicative ability; conditions preventing cooperation as judged by study physicians; as well 
as coincident participation in any other intervention trial [27]. With these recruitment, inclusion/ 
exclusion criteria, the participants represent a group with an increased risk for dementia and room for 
improvement, and their mean cognitive performance was less than 0.5 SD below the average level of 
cognitively normal population [27,30]. In terms of neuropathology, the proportion of participants 
with brain amyloid accumulation is intermediate between healthy older adults and AD patients (11C-
Pittsburgh compound B -PET imaging conducted in a sub-sample of participants) [31].  
 
During the study, 24 participants (7.9 %) in the current analytic sample discontinued. Main reasons 
were health related issues (12 participants), lack of time or motivation (4 participants) and unknown 
reasons (4 participants). Participant characteristics are reported in Table 1.  
 
Assessment of cognitive performance 
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Cognitive performance was measured at baseline and 1- and 2-year follow-ups, using a modified 
Neuropsychological Test Battery (NTB), known to be a reliable and sensitive measure of the mild 
cognitive changes typical for AD [32], expanded with additional tasks to detect executive 
dysfunction. Assessment was administered by trained study psychologists.  
 
The NTB consisted of 14 tests from three different cognitive domains: The memory domain 
included Visual Paired Associates immediate and delayed; Logical Memory immediate and delayed 
from the Wechsler Memory Scale-Revised (WMS-III, WMS-R) [33]; and Word List Learning and 
Delayed Recall from the CERAD battery [29]. The executive-function domain included tests of 
Category Fluency [34], Digit Span [33], Concept Shifting (CST) [35] (condition C), Trail Making 
(TMT) [36] (shifting score B-A), and a shortened 40-stimulus version of the original Stroop test [37] 
(interference score 3–2). The processing-speed domain included Letter Digit Substitution (LDST) 
[38], Concept Shifting (condition A) and Stroop (condition 2).  
 
Zero-skewness log-transformation was applied to skewed NTB components, and standardized z 
scores were calculated. NTB total score and domain scores for memory, executive functioning, and 
processing speed were obtained by averaging individual NTB component z scores. Z scores for tests 
at each timepoint were standardized to the baseline mean and SD of the total FINGER population 
(n=1260). Because of missing values, the minimum number of necessary NTB components was set 
to 8/14 for calculating the NTB total score, 3/5 for executive functioning, 2/3 for processing speed, 
and 3/6 for memory. A higher NTB score indicates better performance.  
 
Assessment of subjective memory performance  
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Participants completed the PRMQ, and the informant version of PRMQ was given at the 6-month 
visit.  PRMQ is a 16-item self-report measure of memory failures in everyday life [19]. Eight items 
inquire about PM and eight about RM. Each item has 5 response alternatives: Very often, quite often, 
sometimes, rarely or never. The PM questions enquire e.g. how often the participant decides to do 
something in a few minutes and then forgets to do it, or if he/she forgets appointments if not prompted 
by someone or by reminder such as calendar. The RM questions enquire e.g. does the participant 
forget something he/she was told a few minutes earlier, or if he/she repeats the same story to the same 
person on different occasions. The score ranges from 16 to 80. Higher scores indicate more SMCs. 
Both PRMQ and the informant version have acceptable reliability and validity [18,19].  Participants 
with missing values for any of the PRMQ items were excluded from analyses (n=15 for participant 
PRMQ and n=42 for informant PRMQ). In addition to continuous PRMQ values, also dichotomous 
variables (using median-value cutoffs) were used (PRMQ total > 36 and sub domains > 18). 
 
Other questionnaires and measures  
 
Participants completed at baseline visit several questionnaires inquiring about lifestyles, health status, 
mood, and quality of life. Depressive symptoms were assessed by the Zung Self-Rating Depression 
Scale [39], and quality of life was evaluated by the RAND-36 [40] Data on subjective health status 
were collected, using a 5-point Likert-scale (1=very good, 5=very poor). Self-reported frequency of 
leisure time physical activities causing sweating and breathlessness lasting at least 20 minutes at least 
twice a week was regarded as being physically active. Education was measured as number of years 
of schooling. Genomic DNA was extracted from venous blood samples with Chemagic MSM1 from 
PerkinElmer using magnetic beads. APOE genotyping was determined by polymerase chain reaction 
using TaqMan genotyping assays (Applied Biosystems (ABI), Foster City, CA, USA) for two single-
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nucleotide polymorphisms (rs429358 and rs7412) and an allelic discrimination method on the ABI 
7500 platform [41].  
 
Statistical analyses 
 
All statistical analyses were performed using IBM SPSS Statistics version 22. Level of significance 
was set at p=.05 in all analyses.  
 
Descriptive statistics were used to characterize the study population. Linear mixed effects regression 
modeling was applied with Maximum likelihood estimation method. Change in cognitive test scores 
was modeled as a function of PRMQ or its subdomains, time and the PRMQ x time interaction. 
Variables considered as possible confounding factors were entered into models. These were included 
as fixed effects in linear mixed model. Specifically, we adjusted for age, sex, study site, education, 
and depression (model 1), and additionally for marital status, subjective health, physical activity and 
APOE 4 status (model 2). Covariates in the model 2 were not related to the outcome. Next, we 
investigated the covariate x time interactions by adding them one by one to model 1. In the final 
model (model 3), we took into account the same covariates as in the model 1 and, additionally, 
covariate x time interactions for those that were significant in previous analytical steps (age x time 
and depression x time). Self-reported and informant-reported PRMQ scores were first analyzed 
separately, and in the last model simultaneously and with other covariates as in the model 1. 
 
RESULTS 
 
Participant characteristics  
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There were 303 participants (women=155; men=148). Participant characteristics and baseline 
cognitive performance are reported in Tables 1 and 2. Self-reported PRMQ data were available for 
288 participants and informant-based PRMQ data for 261 participants. Mean score on total PRMQ 
reported by the participants was 36.0, and by the informants 30.4 (p<0.001 for the difference between 
participant and informant ratings). No significant difference was found between PM and RM 
problems reported by participants (p>0.07). Informants reported more PM than RM problems 
(p=0.001).  
 
Self-reported SMCs and change in neuropsychological performance 
 
Overall, cognitive performance improved during two year follow-up (p<0.001). Mean change in NTB 
total score was 0.12 (SD 0.35). Reporting more memory complaints (higher PRMQ total) was related 
to less improvement in NTB total score and in memory even after full adjustments (Table 3). Higher 
PRMQ total score was also linked to reduced improvement in executive function, but the association 
was attenuated after adjustments. PRMQ total score was unrelated to change in processing speed. 
 
PM complaints predicted less improvement in NTB total score and memory, although these 
associations were somewhat diluted with full adjustments. PM scores were not associated with change 
in either processing speed or executive function. RM complaints predicted less improvement in all 
cognitive domains, except processing speed.  
 
Regarding dichotomous PRMQ variables, those with more reported PRMQ total or RM problems 
(PRMQ total > 36; RM > 18) improved less in NTB total score compared with those who reported 
fewer memory problems (Figure 1). The mean difference between groups reporting more PRMQ 
problems compared with less PRMQ problems (group x time interaction) in change in NTB total 
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score per year was -0.062 (95 % CI -0.108 to -0.017) for PRMQ total and -0.075 (-0.120 to -0.030) 
for RM. Reporting more PM problems (> 18) was not significantly associated with change in NTB 
total score; estimate -0.033 (-0.078 to 0.012). 
 
Informant-reported SMCs and change in neuropsychological performance 
 
Informant reported data were received from participants’ spouses (48.3%), children (13.3%), and 
significant others (13.0%). Information on the relationship with the participant was missing for 
25.3%. More informant-reported SMCs (higher PRMQ total score) was linked to less improvement 
in executive function, but this effect fell short of significance after full adjustments (Table 3). 
Informant PRMQ total score was not associated with change in NTB total, processing speed or 
memory domains. Informant PM or RM complaints were unrelated to change in any cognitive domain 
after full adjustments. These patterns remained unchanged in sensitivity analyses within the group of 
spouses only.  
 
Participant and informant PRMQ ratings analyzed simultaneously and change in neuropsychological 
performance 
 
When both self and informant reports were adjusted for each other, self-reported PRMQ total score 
was associated with all other cognitive domains, except processing speed. Self-reported RM 
complaints predicted less improvement in all cognitive domains, and PM complaints were related to 
NTB total score and processing speed. Informant reports for PM complaints were associated with 
improvement in processing speed (Table 3).  
 
DISCUSSION 
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The aim of this study was to examine whether self-reported or informant reported SMCs predict 2-
year cognitive change among healthy, but at-risk elderly people. The results show that having more 
self-reported SMCs, measured with the PRMQ predicts poorer development in NTB total and 
memory scores. Subjective RM problems, but not PM problems, predicted less improvement in NTB 
total, memory, and executive functions. Informant ratings in PRMQ total and PM and RM subscales 
were not associated with any cognitive domain after adjustments.  
 
The question of whether self or informant reports are more predictive of future cognitive decline is 
complex, and depends on the time of the assessment. In contrast to some previous studies suggesting 
informant reports to be more predictive [2,17,42] when assessing self and informant reports 
simultaneously, our study found self-reports to be more accurate in predicting future cognitive 
change. Our older sample was cognitively healthy but at risk, whereas most previous studies were 
based on memory-clinic patients or persons with MCI. To our knowledge, this is the first study 
assessing both subjective PM and RM complaints simultaneously among both participants and their 
informants in relation to cognitive performance across several domains. Overall we were seeing an 
improvement in cognitive performance in our sample [23]. Such a pattern is quite common in 
longitudinal studies of cognitive aging with relatively short retest intervals and likely reflects placebo 
effects or practice effects of repeated cognitive testing. Also one other study has shown that 
cognitively normal individuals converting to MCI self-recognized decline earlier than informants 
[43]. In the current study, the changes noted by the informants (even if attenuated with full 
adjustments), were in fact linked to future changes in executive functions rather than to memory. 
When participant and informant reports were adjusted for each other, we observed that while 
participant-reported PM complaints were associated with less improvement in processing speed, 
informant-reported PM complaints were associated with more improvement.  
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One previous study that investigated informant reports of PM and RM problems among participants 
with memory problems or early AD found that especially PM problems were linked to objective 
cognitive outcomes [22]. The present findings suggest that informant PM and RM reports are only 
weakly related to cognitive changes. Surprisingly, subjective PM problems were less associated with 
future cognitive change than RM problems; PM has been suggested to be more vulnerable than RM 
to changes in the early phase of AD [22,44]. It has also been suggested that PM functions are 
especially important from an independent living point of view [45], and, therefore, more easily 
observed than RM problems. It could be that commonly used memory tests, as those included in our 
study, evaluate RM function more accurately than PM function. Self-reported PM and RM complaints 
have rarely been compared. One previous study suggested that self-reported RM but not PM 
complaints were helpful in differentiating elderly persons with subjective cognitive impairment and 
amnestic mild cognitive impairment, which is in line with the current results [46].  
 
Decline in cognitive function, including both episodic memory and executive function may begin 
decades before diagnosis of dementia [47]. Even though the participants in our study did not face 
cognitive difficulties causing functional decline, their reports of memory problems were relevant for 
future changes in memory and executive function. Informant reports were somewhat linked to 
changes in executive function. Perhaps changes in executive functions can be earlier and more easily 
observed because of their relevance for everyday performance [48]. 
 
Affective factors in the individual or the informant or the quality of the relationship between the two 
might inﬂuence the subjective evaluations [49]. In addition to the depressive symptoms alone being 
an independent risk factor for dementia [50], these symptoms may affect the subjective experience of 
cognitive deficits, including memory problems [51].  In one study [52] cognitive and memory 
14 
 
complaints were more closely associated with mood and general mental health than actual cognitive 
status. Toward this end, the associations observed between participant-reported SMCs and cognitive 
performance (NTB total, executive functions, and memory), and between informant- reported SMCs 
and cognition (executive functions), remained significant after adjusting for depressive symptoms.  
 
This study has a number of strengths. The study population is drawn from earlier population-based 
studies, and with the inclusion criteria used, the population can be seen representative of the normal 
Finnish population with some risk factors for dementia, and cognitive functioning at the average level 
or slightly below the average of this age group [27]. Note that the study included only high-risk 
individuals, not participants already diagnosed with dementia. The richness of the data collected 
allowed adjusting for many possible confounding factors. In assessing neuropsychological 
performance, we used a comprehensive and standardized NTB comprising measurements of several 
key cognitive domains and a psychometrically validated [19] method for assessing SMCs. Finally, 
the drop-out rate was only 8 % after 2 years. 
 
The limitations include: the timing of the subjective memory assessment, as participants completed 
the PRMQ six months after the first neuropsychological testing. However, no major changes in 
memory functions or their subjective assessments are likely to have occurred during this time period.  
Because of the long preclinical stage before clinical dementia, it is possible that some participants 
might already have had some dementia-related brain changes. MCI diagnostics was not done and 
some of the participants might have fulfilled MCI criteria at baseline (depending on the criteria used). 
However, mean cognitive performance was less than 0·5 SD below the average level for the 
cognitively normal Finnish population [30]. The duration of the 2-year follow-up time was fairly 
short to track the progression of cognitive decline. However, studies with longer follow-up periods 
have reported similar results and shown SMCs to predict future diagnostic outcomes and later 
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progression to AD [2,53]. Due to a relatively small sample size our study may have had limited power 
to detect some moderate degree associations that may have existed. Although there are no validation 
studies or norms for the PRMQ in the Finnish population, the questionnaire is widely used and can 
be viewed as culturally neutral. No alternate versions of the cognitive tests were used which may 
have contributed to the magnitude of the observed improvement in cognitive performance over time.  
 
In sum, our findings indicate that self-reported SMCs, measured with the PRMQ among cognitively 
healthy older adults at increased risk of cognitive decline, predict 2-year cognitive changes. The results 
are in line with previous findings that underscore the usefulness of subjective memory assessment in 
identifying individuals at risk of future cognitive impairment or eventually dementia [2]. Compared 
with informant reports, self-reported memory failures seem to be more sensitive indicators for 
predicting cognitive change in this relatively healthy population. 
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Table 1. Baseline characteristics of the participants (mean, standard deviation (SD) or %) and 
cognitive performance in different domains during study 
Characteristic   N mean / % SD 
Baseline characteristics 
Age (years)    303 70.0 4.9 
Sex (% men/ women)    303 48.8/51.2 
Education (years)    303 10.2 3.4 
Married / cohabiting (%)   303 71.6  
Zung self-rating depression scale*  294 35.8 7.6 
Subjective health (quite good or very good, %) 302 58.6  
Physically active (%)   300 70.6 
PRMQ ratings / subscales 
Participants total*  288 36.0 7.8 
 prospective*  298 17.9 4.2 
retrospective*  293 18.1 4.2 
Informants total*  261 30.4 9.9 
 prospective*  272 15.5 5.3 
 retrospective*  266 15.0 5.0 
Mini-Mental State Examination (MMSE) 303 27.0 2.0 
Study site Helsinki  (n, %)  37 12.2 
 Vantaa  (n, %)  44 14.5 
Kuopio  (n, %)  107 35.3 
Turku  (n, %)  115 38.0 
Apoliproprotein E ɛ4 carriers (n, %)  285 34.7  
Cognitive performance during study** 
Baseline NTB total   302 0.0 0.6 
 Processing speed  302 0.0 0.9 
 Executive functions  302 0.0 0.7 
 Memory   302 0.0 0.6 
12 months NTB total   295 0.1 0.7  
 Processing speed  295 0.1 0.9 
 Executive functions  295 0.0 0.7 
 Memory   295 0.2 0.8 
24 months NTB total   277 0.2 0.7  
 Processing speed  277 0.0 0.9 
 Executive functions  276 0.1 0.7  
 Memory   278 0.3 0.8 
PRMQ=Prospective and Retrospective Memory Questionnaire; NTB=Neuropsychological test 
battery. 
*Range for possible scores: Zung scale (20-80); PRMQ total (16-80); PRMQ prospective score (8-
40), PRMQ retrospective score (8-40); MMSE (0-30). Higher scores on PRMQ indicate presence of 
more complaints. 
**Higher scores on NTB total and domain scores indicate better cognitive performance. 
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Table 2. Cognitive performance at baseline (mean, standard deviation (SD)) 
Neuropsychological test   N Mean SD 
Memory       
WMS-R Logical Memory (immediate)  301 11.0 3.4  
WMS-R Logical Memory (delayed)  301 9.4 3.6 
CERAD Word List Learning  303 18.3 3.2  
CERAD Word List Recall   302 5.5 1.6 
WMS-R Visual Paired Associates (immediate) 297 9.6 3.6 
WMS-R Visual Paired Associates (delayed) 296 3.5 1.8 
Executive Function 
CERAD Category Fluency   303 22.4 5.5 
WMS-R Digit Span (total)   301 11.3 2.8  
CST (condition C) *   293 65.9 39.0  
TMT shifting score (B-A) *  292 103.7 63.3  
Stroop test interference score (3-2) *  301 35.0 18.4  
Processing speed 
LDST    300 21.8 5.8  
CST (condition A) *   301 32.9 10.1  
Stroop test (condition 2) *   301 28.9 6.5 
* Timed task where lower scores indicate faster performance/better test results. In other tasks, 
higher numbers indicates better results. WMS-R=Wechsler Memory Scale-Revised, 
CERAD=Consortium to Establish a Registry for Alzheimer’s Disease, CST=Concept Shifting Test, 
TMT=Trail Making Test, LDST=Letter Digit Substitution Test  
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Table 3. The association between self-reported and informant-reported prospective and retrospective memory complaints (measured with 
Prospective and Retrospective Memory Questionnaire, PRMQ) and change in cognitive function during 2 years. Results are from mixed linear 
models (estimates of PRMQ effect per year and p values). 
  
 
 
MODEL 1 
 
Participants 
 
MODEL 2 
 
 
 
MODEL 3 
  
 
 
MODEL 1 
 
Informants 
 
MODEL 2 
 
 
 
MODEL 3 
 Estimate of 
PRMQ for change 
in cognition per 
year (p-value) 
Estimate of 
PRMQ for change 
in cognition per 
year (p-value) 
Estimate of 
PRMQ for change 
in cognition per 
year (p-value) 
 Estimate of PRMQ 
for change in 
cognition per year 
(p-value) 
Estimate of PRMQ 
for change in 
cognition per year 
(p-value) 
Estimate of PRMQ 
for change in 
cognition per year 
(p-value) 
 
Total PRMQ 
       
NTB total -0.004 (0.001) -0.004 (0.002) -0.003 (0.015)  -0.002 (0.082) -0.002 (0.073) -0.001 (0.459) 
Processing speed            -0.003 (0.109) -0.003 (0.093) -0.002 (0.253)  0.001 (0.446) 0.001 (0.436) 0.002 (0.172) 
Executive functions -0.003 (0.037) -0.003 (0.049) -0.003 (0.101)  -0.003 (0.019) -0.003 (0.025) -0.002 (0.071) 
Memory -0.006 (0.005) -0.006 (0.011) -0.005 (0.047)  -0.003 (0.106) -0.003 (0.092) -0.001 (0.443) 
 
Prospective memory 
       
NTB total -0.006 (0.020) -0.005 (0.034) -0.004 (0.117)  -0.003 (0.168) -0.003 (0.159) -0.001 (0.649) 
Processing speed            -0.004 (0.234) -0.004 (0.245) -0.003 (0.411)  0.004 (0.181) 0.004 (0.200) 0.005 (0.051) 
Executive functions -0.004 (0.190) -0.003 (0.244) -0.003 (0.367)  -0.005 (0.042) -0.004 (0.053) -0.004 (0.115) 
Memory -0.008 (0.045) -0.008 (0.073) -0.006 (0.198)  -0.005 (0.150) -0.005 (0.141) -0.003 (0.460) 
 
Retrospective memory 
       
NTB total -0.009 (<0.001) -0.009 (<0.001) -0.007 (0.005)  -0.004 (0.075) -0.004 (0.062) -0.002 (0.398) 
Processing speed            -0.006 (0.062) -0.006 (0.040) -0.004 (0.182)  0.001 (0.776) 0.004 (0.762) 0.002 (0.408) 
Executive functions -0.007 (0.013) -0.007 (0.016) -0.006 (0.048)  -0.005 (0.028) -0.005 (0.037) -0.004 (0.094) 
Memory -0.013 (0.002) -0.012 (0.004) -0.010 (0.026)  -0.006 (0.107) -0.007 (0.080) -0.003 (0.419) 
        
PRMQ=Prospective and Retrospective memory questionnaire 
Model 1. Adjusted for age, sex, study site, education and depression.  
Model 2.  Adjusted for age, sex, study site, education, depression, marital status, subjective health, physical activity and ApoE4 allele.  
Model 3.  Adjusted for age, sex, study site, education and depression and interactions with time and age and depression. 
Higher scores on PRMQ indicate presence of more complaints. Higher scores on cognitive outcomes indicate better cognitive performance. 
Significant effects are in bold typeface.  
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Table 4. The association between self-reported and informant-reported prospective and 
retrospective  memory complaints (measured with Prospective and Retrospective Memory 
Questionnaire, PRMQ) and change in cognitive function during 2 years. Participant and 
informant repots are adjusted for each other. Results are from mixed linear models (estimates 
of PRMQ effect per year and p values). 
 
Reports 
 
Participants 
 
Informants 
 Estimate of 
PRMQ for 
change in 
cognition per 
year (p-value) 
Estimate of 
PRMQ for 
change in 
cognition per 
year (p-value) 
 
Total PRMQ 
  
NTB total -0.005 (0.001) -0.000 (0.745) 
Processing speed            -0.005 (0.010) 0.003 (0.057) 
Executive functions -0.003 (0.110) -0.002 (0.119) 
Memory -0.006 (0.013) -0.001 (0.579) 
 
Prospective memory 
  
NTB total -0.006 (0.021) -0.001 (0.733) 
Processing speed            -0.008 (0.036) 0.006 (0.032) 
Executive functions -0.003 (0.295) -0.004 (0.145) 
Memory -0.008 (0.098) -0.003 (0.444) 
 
Retrospective memory 
  
NTB total -0.010 (<0.001) -0.001 (0.712) 
Processing speed            -0.010 (0.007) 0.004 (0.155) 
Executive functions -0.006 (0.038) -0.004 (0.163) 
Memory -0.013 (0.005) -0.002 (0.580) 
   
PRMQ=Prospective and Retrospective memory questionnaire 
Model adjusted for age, sex, study site, education and depression, and self and informant 
reports are entered simultaneously.  
Higher scores on PRMQ indicate presence of more complaints. 
Higher scores on cognitive outcomes indicate better cognitive performance. 
Significant effects are in bold typeface. 
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Figure 1. Cognitive changes during 2 year follow-up time as a function of subjective 
memory assessment; part A for total PRMQ; part B for prospective memory; and part C for 
retrospective memory.  The figure shows estimated mean change in cognitive performance 
from baseline through 12 and 24 months (higher scores indicate better performance). Error 
bars are standard errors around the means. Mixed-model repeated-measures analyses were 
used to assess between-group diﬀerences (higher/lower subjective memory complaints ) in 
changes from baseline to 24 months based on data from participants with at least one post-
baseline measurement. Low and high refer to the amount of reported subjective memory 
complaints below or above the median level (using cutoffs: PRMQ total > 36 and sub 
domains > 18) 
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